Futura Medical Plc Overview
Pro stress-test →Futura Medical is a UK-based pharmaceutical company specializing in topical sexual health treatments. The company developed Eroxon, a topical gel for erectile dysfunction that received regulatory approval in the EU and US, and is pursuing additional indications including WSD4000 for female sexual dysfunction.
Strategic Profile
Pro stress-test →Futura leverages proprietary DermaSys transdermal delivery technology for topically applied products. Despite securing commercial partnerships with Cooper Consumer Health (EU) and Haleon (US), the company has faced significant commercialization challenges, with Eroxon failing to achieve expected market traction despite regulatory wins.
Competitive Landscape
Pro stress-test →Futura competes in the sexual health pharmaceutical market against established players and generic competitors. The company's topical approach differentiates from oral medications, but execution challenges have hampered competitive positioning. Key partnership relationships with Haleon and Cooper Consumer Health provide distribution but have not translated to commercial success.
Industry Context
Futura Medical Plc operates in Pharmaceutical - Sexual Health / Specialty Care.
Key facts
Founded: 2001 · Headquarters: Guildford, UK · Revenue: £1.3m - £1.4m (full year 2025 projection) · Market cap: £7.7m